⚕ GalenOps CRO console
← 701 (USA)

701-1180

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2013-02-12
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-19 (study day 36.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-19 (study day 36.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE VESICLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-19 (study day 36.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2002; relationship: NONE

mild assessed 2026-08-18

Mild MICTURITION URGENCY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-15 (study day 4.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild MICTURITION URGENCY — outcome: RECOVERED/RESOLVED; onset 2013-02-15 (study day 4.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2013-03-06 (study day 23.0); relationship: NONE

mild assessed 2026-08-18

Mild VOMITING — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-12 (study day 1.0); relationship: NONE

mild assessed 2026-08-18

Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-02-12 (study day 1.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.